Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
New England Journal of Medicine · 16.01.2025 · 392 (3) · 249-257
DOI: 10.1056/nejmoa2406070 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 16.01.2025. Verfasst von Charles E Geyer und 34 weiteren Autor:innen. Beteiligte Einrichtung: From the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation (C.E.G., E.P.M., N.W., P.R., I.L.W., A.M.B.) and University of Pittsb…. Hauptthemen laut MEDLINE: Ado-Trastuzumab Emtansine, Antineoplastic Agents, Immunological, Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 168-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Genentech.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation (C.E.G., E.P.M., N.W., P.R., I.L.W., A.M.B.) and University of Pittsburgh School of Medicine-UPMC Hillman Cancer Center (C.E.G., N.W., P.R.…
Förderung
- Genentech
Zitieren
APA
Geyer, C. E., Untch, M., Huang, C. S., Mano, M. S., Mamounas, E. P., Wolmark, N., Rastogi, P., Schneeweiss, A., Redondo, A., Fischer, H. H., D'Hondt, V., Conlin, A. K., Guarneri, V., Wapnir, I. L., Jackisch, C., Arce-Salinas, C., Fasching, P. A., DiGiovanna, M. P., Crown, J. P., …, & KATHERINE Study Group (2025). Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer. New England Journal of Medicine, 392(3), 249-257. https://doi.org/10.1056/nejmoa2406070
Vancouver
Geyer CE, Untch M, Huang CS, Mano MS, Mamounas EP, Wolmark N, et al. Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer. New England Journal of Medicine. 2025;392(3):249-257. doi:10.1056/nejmoa2406070
BibTeX
@article{Geyer2025,
author = {Geyer, Charles E and Untch, Michael and Huang, Chiun-Sheng and Mano, Max S and Mamounas, Eleftherios P and Wolmark, Norman and Rastogi, Priya and Schneeweiss, Andreas and Redondo, Andres and Fischer, Hans H and D'Hondt, Véronique and Conlin, Alison K and Guarneri, Valentina and Wapnir, Irene L and Jackisch, Christian and Arce-Salinas, Claudia and Fasching, Peter A and DiGiovanna, Michael P and Crown, John P and Wuelfing, Pia and Shao, Zhimin and Rota Caremoli, Elena and Bonnefoi, Hervé R and Hennessy, Bryan T and Stamatovic, Ljiljana and Castro-Salguero, Hugo and Brufsky, Adam M and Knott, Adam and Siddiqui, Asna and Lambertini, Chiara and Boulet, Thomas and Nyawira, Beatrice and Restuccia, Eleonora and Loibl, Sibylle and KATHERINE Study Group, KATHERINE Study Group},
title = {Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {3},
pages = {249--257},
doi = {10.1056/nejmoa2406070}
}
EUVIMED